SIRT1 and diabetic kidney disease: Additionally, inhibition of miR-150-5p promotes the interaction between SIRT1 and p53, reduces p53 acetylation in podocytes and renal tissue, and exerts a protective effect on the kidney in DKD mice (Dong et al., 2021).